Adverse Drug Reaction Update
Copyright policy )Adverse Drug Reaction Update
Increasing numbers of articles on adverse drug reactions are published in a wide range of medical journals. To help keep you up-to-date with the latest advances worldwide on all aspects of adverse drug reactions, this section of the journal brings you information selected from the drug safety alerting service Reactions Weekly. The following reports are selected from the latest issues, summarizing the most important clinical studies, adverse reaction news, and expert opinion pieces published across a broad range of literature sources.
Adult, Thioridazine, Pirenzepine, Vigabatrin, Europe, Benzodiazepines, Olanzapine, Pyrones, Adverse Drug Reaction Reporting Systems, Humans, Child, Bupropion, Carbolines, Epirubicin
Adult, Thioridazine, Pirenzepine, Vigabatrin, Europe, Benzodiazepines, Olanzapine, Pyrones, Adverse Drug Reaction Reporting Systems, Humans, Child, Bupropion, Carbolines, Epirubicin
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).1 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!